Medical devices, healthcare technology and the business of care
FDA RECALL RECORD · Z-1609-2025

Medline Convenience kits used for various procedures: 1) HERNIA REPAIR TOTE Recall

Medline Convenience kits used for various procedures: 1) HERNIA REPAIR TOTE, Model Number: DYNJ908337C

FDA recall Class II

Ongoing

FDA lists this Class II recall for Medline Convenience kits used for various procedures: 1) HERNIA REPAIR TOTE. Review the affected identifiers, reported reason and manufacturer instructions below.

Recall at a glance

Recall number
Z-1609-2025
Recall classification
Class II
Enforcement status
Ongoing
Initiation date
Mar 3, 2025
FDA report date
Apr 23, 2025
Quantity in commerce
40 units
Distribution
See key details
FDA cause
Under Investigation by firm

What is being recalled?

Medline Convenience kits used for various procedures: 1) HERNIA REPAIR TOTE, Model Number: DYNJ908337C

Affected model & UDI checker

Search the exact identifiers published for Z-1609-2025.

The lookup covers structured identifiers listed on this page. A full UDI may also contain lot or serial information; a GTIN match alone does not check those conditions.

Affected products

Model / catalog numberProductLot scope reportedUDI / GTIN
DYNJ908337CMedline Convenience kits used for various procedures: 1) HERNIA REPAIR TOTECheck source noticeNot specified
Not specifiedMedline Convenience kits used for various procedures: 1) HERNIA REPAIR TOTECheck source notice10198459085925
Not specifiedMedline Convenience kits used for various procedures: 1) HERNIA REPAIR TOTECheck source notice40198459085926
FDA code information

1) DYNJ908337C, UDI-DI: 10198459085925(each), 40198459085926(case), Lot Number: 24KBK455

View the original FDA recall notice

Why was this product recalled?

There is a potential for open/weak seals on purchased breather pouches used for packaging of select sterile convenience kits.

These are potential consequences described in the source. The recall reason does not establish how many injuries or incidents occurred.

What actions did MEDLINE INDUSTRIES, LP - Northfield take?

An IMMEDIATE ACTION REQUIRED MEDLINE DEVICE RECALL notification letter dated 3/3/25 was sent to customers. REQUIRED ACTION: 1.Immediately check your stock for the affected item number and the affected lot numbers which can be located within the recall portal. 2.Please use the link and the information below to complete your response form. Please list the quantity of affected product you have in inventory on the form. Even if you do not have any affected product in inventory, please complete and submit the response form. 3.Please destroy any affected inventory. Medline will issue credit for the product based upon the quantity and lot numbers identified on the submitted response form The login for completing the response form is: Website link: https://recalls.medline.com Recall Reference #: R-25-050-FG Recall Code: RECALL CODE 4.If you are a distributor, or have resold or transferred this product to another company or individual, you are required by FDA regulations to notify them of this recall communication. Please request that customers document and destroy any affected product, and include your customer s quantities on your response form. If you have any questions, contact the Recall Department at 866-359-1704 or recalls@medline.com.

Read the manufacturer action recorded by FDA

Recall timeline

  1. Recall initiated by firm

  2. FDA notice posted

  3. FDA classification recorded

  4. FDA enforcement report date

Related FDA submissions

No submission number with an exact verified relationship is linked in the retrieved recall notice.

FDA’s notice explicitly links the submission numbers shown here. Read each filing for its own recorded device and scope.

Source and update history

  1. FDA enforcement data

    First stored snapshot of this source.

  2. FDA device-recall notice

    First stored snapshot of this source.

The history starts with the versions held by MedtechLedger. Earlier source changes are not reconstructed. Official dates and recorded status come from FDA; page summaries describe the source information.

Our data sources and methodology